Market Overview:
The Global Drug Closed System Transmission Market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of hospital-acquired infections (HAIs), rising demand for minimally invasive surgeries, and technological advancements in drug closed system transmission devices. Based on type, the market is segmented into closed vial access devices, closed syringe safety devices, and closed bag/line access devices. The closed vial access device segment accounted for the largest share of the global drug closed system transmission market in 2017 owing to its high adoption rate across hospitals and clinics worldwide. By application, the hospital segment accounted for the majority share of the global drugclosed system transmission market in 2017 due to increasing number of surgical procedures performed in hospitals globally.
Product Definition:
A drug closed system transmission is a device that is used to prevent the contamination of drugs with other substances. This type of device is important because it helps to ensure that the drugs are pure and uncontaminated.
Closed Vial Access Device:
Closed vial access devices (CVAD) are used to deliver medicines in intravenous drug therapy. CVADs can be classified into two types depending on the method of operation, namely syringe-based and pump-based systems. The major factor that differentiates these two is the way medicine is administered; while syringe-based system requires a skilled user for administration, pump-based system allows an automated mode of administration.
Closed Syringe Safety Device:
Closed syringe safety device is a new innovative technology that helps in preventing contamination and adulteration during drug manufacturing, packaging, dispensing & delivery. It also helps to ensure patient safety by protecting the contents of vials from external contamination. The device consists of a syringe with attached needle cover which can be used for drawing up liquid or semi-liquid drugs into the syringe barrel without fear of introducing extraneous materials into the medication.
Application Insights:
Based on application, the global drug closed system transmission market is segmented into hospital, clinic and others. The hospital segment dominated the market in 2017 owing to factors such as increasing prevalence of chronic diseases and rising geriatric population. Moreover, government initiatives such as National Cholesterol Education Program (NCEP) guidelines promoting lifestyle modification for reducing blood cholesterol levels are expected to drive demand over the forecast period.
The other application segment includes dental clinics, home healthcare services and other outpatient facilities. Increasing awareness about HIV among people especially in developing countries is anticipated to increase demand for antiretroviral drugs leading to an increase in safety measures including needle disposal devices used during injections at these facilities which will have a positive impact on market growth over the forecast period.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position during the forecast period. The growth of this region can be attributed to various factors such as increasing government initiatives, rising awareness about blood safety, and presence of key companies in Asian countries. Moreover, growing medical tourism industry in emerging economies like India and China is expected to boost demand for these systems over the forecast period.
Europe accounted for a significant share owing to high incidence of hospital-acquired infections across hospitals in U.K., Germany, Italy, Spain & France coupled with stringent regulatory environment towards quality standards associated with medicines consumption across these nations which resulted into high adoption rate of drug closed system transmission devices among healthcare professionals working within Europe region from 2018 to 2030 forecasted period.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the global drug closed system transmission market. This is because drug closed system transmission helps in preventing cross contamination and also helps in reducing the risk of infection.
- Rising demand for minimally invasive surgeries: The rising demand for minimally invasive surgeries is another key growth driver for the global drug closed system transmission market. This is because minimally invasive surgeries help in reducing patient trauma, hospital stay, and surgical time.
- Technological advancements: The technological advancements are another key growth driver for the global drug closed system transmission market as they help in improving product efficiency and performance while reducing costs associated with surgery procedures. For instance, introduction of disposable products has helped reduce environmental impact and improve safety standards across hospitals worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Closed System Transmission Market Research Report
By Type
Closed Vial Access Device, Closed Syringe Safety Device, Closed Bag/Line Access Device
By Application
Hospital, Clinic, Other
By Companies
Equashield, BD Medical, Teva Medical, ICU Medical, Corvida Medical, B. Braun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Drug Closed System Transmission Market Report Segments:
The global Drug Closed System Transmission market is segmented on the basis of:
Types
Closed Vial Access Device, Closed Syringe Safety Device, Closed Bag/Line Access Device
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Equashield
- BD Medical
- Teva Medical
- ICU Medical
- Corvida Medical
- B. Braun
Highlights of The Drug Closed System Transmission Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Closed Vial Access Device
- Closed Syringe Safety Device
- Closed Bag/Line Access Device
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Closed System Transmission Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug closed system transmission is a process in which the drug leaves the body through the digestive tract and enters into the blood stream.
Some of the key players operating in the drug closed system transmission market are Equashield, BD Medical, Teva Medical, ICU Medical, Corvida Medical, B. Braun.
The drug closed system transmission market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Closed System Transmission Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Closed System Transmission Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Closed System Transmission Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Closed System Transmission Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Closed System Transmission Market Size & Forecast, 2020-2028
4.5.1 Drug Closed System Transmission Market Size and Y-o-Y Growth
4.5.2 Drug Closed System Transmission Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Closed Vial Access Device
5.2.2 Closed Syringe Safety Device
5.2.3 Closed Bag/Line Access Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Closed System Transmission Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Closed System Transmission Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Closed Vial Access Device
9.6.2 Closed Syringe Safety Device
9.6.3 Closed Bag/Line Access Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Closed Vial Access Device
10.6.2 Closed Syringe Safety Device
10.6.3 Closed Bag/Line Access Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Closed Vial Access Device
11.6.2 Closed Syringe Safety Device
11.6.3 Closed Bag/Line Access Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Closed Vial Access Device
12.6.2 Closed Syringe Safety Device
12.6.3 Closed Bag/Line Access Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Closed Vial Access Device
13.6.2 Closed Syringe Safety Device
13.6.3 Closed Bag/Line Access Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Closed System Transmission Market: Competitive Dashboard
14.2 Global Drug Closed System Transmission Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Equashield
14.3.2 BD Medical
14.3.3 Teva Medical
14.3.4 ICU Medical
14.3.5 Corvida Medical
14.3.6 B. Braun
